Regulatory tracker: FDA nod for AbbVie's Mayvret allows it to be provided immediately upon hep C diagnosis

In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not meet the bar for standalone stories, but we think they are still worth mentioning.

Jun 11, 2025 - 20:20
 0
Regulatory tracker: FDA nod for AbbVie's Mayvret allows it to be provided immediately upon hep C diagnosis
In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not meet the bar for standalone stories, but we think they are still worth mentioning.